Encompass Health Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Encompass Health wird ein jährliches Gewinn- und Umsatzwachstum von 9.1% bzw. 7.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.2% betragen.
Wichtige Informationen
9.1%
Wachstumsrate der Gewinne
6.1%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 19.3% |
| Wachstumsrate der Einnahmen | 7.7% |
| Zukünftige Eigenkapitalrendite | 21.2% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 29 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26
Recent updates
Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health (NYSE:EHC) Has Announced A Dividend Of $0.15
Dec 13Encompass Health (NYSE:EHC) Is Due To Pay A Dividend Of $0.15
Nov 28Is There Now An Opportunity In Encompass Health Corporation (NYSE:EHC)?
Nov 21Are Encompass Health Corporation (NYSE:EHC) Investors Paying Above The Intrinsic Value?
Nov 08Is Encompass Health (NYSE:EHC) A Risky Investment?
Oct 10Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Sep 07Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?
Aug 10Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health (NYSE:EHC) Is Paying Out A Dividend Of $0.15
Jul 23Does Encompass Health (NYSE:EHC) Have A Healthy Balance Sheet?
May 22Is Now The Time To Look At Buying Encompass Health Corporation (NYSE:EHC)?
May 01Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Is Now An Opportune Moment To Examine Encompass Health Corporation (NYSE:EHC)?
Jan 23Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$48.81?
Oct 18Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26Encompass Health Encompasses Quality, Defensibility After Q2 FY22
Aug 10Encompass Health Q2 2022 Earnings Preview
Jul 31Encompass Health declares $0.15 dividend
Jul 20Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 6,271 | 506 | 195 | N/A | 6 |
| 12/31/2025 | 5,785 | 469 | 282 | 868 | 11 |
| 12/31/2024 | 5,315 | 423 | 264 | 840 | 11 |
| 6/30/2024 | 5,071 | 409 | 215 | 872 | N/A |
| 3/31/2024 | 4,957 | 387 | 239 | 862 | N/A |
| 12/31/2023 | 4,801 | 362 | 268 | 851 | N/A |
| 9/30/2023 | 4,692 | 357 | 249 | 822 | N/A |
| 6/30/2023 | 4,574 | 336 | 97 | 677 | N/A |
| 3/31/2023 | 4,450 | 280 | 144 | 715 | N/A |
| 12/31/2022 | 4,349 | 256 | 122 | 706 | N/A |
| 9/30/2022 | 4,254 | 232 | 81 | 657 | N/A |
| 6/30/2022 | 4,175 | 242 | 216 | 765 | N/A |
| 3/31/2022 | 3,844 | 253 | 216 | 776 | N/A |
| 12/31/2021 | 4,015 | 298 | 170 | 716 | N/A |
| 9/30/2021 | 4,187 | 316 | 381 | 872 | N/A |
| 6/30/2021 | 4,350 | 318 | 408 | 868 | N/A |
| 3/31/2021 | 4,693 | 304 | 410 | 834 | N/A |
| 12/31/2020 | 3,566 | 193 | 300 | 705 | N/A |
| 9/30/2020 | 4,614 | 265 | 244 | 641 | N/A |
| 6/30/2020 | 4,602 | 285 | 169 | 582 | N/A |
| 3/31/2020 | 4,663 | 342 | 89 | 505 | N/A |
| 12/31/2019 | 4,605 | 358 | 231 | 635 | N/A |
| 9/30/2019 | 4,517 | 317 | 238 | 598 | N/A |
| 6/30/2019 | 4,423 | 308 | 362 | 682 | N/A |
| 3/31/2019 | 4,355 | 309 | 417 | 706 | N/A |
| 12/31/2018 | 4,277 | 290 | 486 | 762 | N/A |
| 9/30/2018 | 4,190 | 339 | 476 | 735 | N/A |
| 6/30/2018 | 4,104 | 316 | 458 | 712 | N/A |
| 3/31/2018 | 4,003 | 288 | N/A | 694 | N/A |
| 12/31/2017 | 3,914 | 271 | N/A | 658 | N/A |
| 9/30/2017 | 3,841 | 260 | N/A | 642 | N/A |
| 6/30/2017 | 3,771 | 256 | N/A | 645 | N/A |
| 3/31/2017 | 3,710 | 256 | N/A | 646 | N/A |
| 12/31/2016 | 3,643 | 247 | N/A | 640 | N/A |
| 9/30/2016 | 3,576 | 228 | N/A | 616 | N/A |
| 6/30/2016 | 3,432 | 217 | N/A | 602 | N/A |
| 3/31/2016 | 3,280 | 198 | N/A | 552 | N/A |
| 12/31/2015 | 3,116 | 181 | N/A | 502 | N/A |
| 9/30/2015 | 2,857 | 173 | N/A | 438 | N/A |
| 6/30/2015 | 2,678 | 172 | N/A | 415 | N/A |
| 3/31/2015 | 2,520 | 204 | N/A | 440 | N/A |
| 12/31/2014 | 2,374 | 208 | N/A | 445 | N/A |
| 9/30/2014 | 2,336 | 144 | N/A | 476 | N/A |
| 6/30/2014 | 2,303 | 148 | N/A | 479 | N/A |
| 3/31/2014 | 2,266 | 228 | N/A | 456 | N/A |
| 12/31/2013 | 2,247 | 229 | N/A | 470 | N/A |
| 9/30/2013 | 2,224 | 293 | N/A | 479 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: EHCDas prognostizierte Gewinnwachstum (9.1% pro Jahr) liegt über der Sparquote (2.5%).
Ertrag vs. Markt: EHCDie Erträge des Unternehmens (9.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.9% pro Jahr).
Hohe Wachstumserträge: EHCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: EHCDie Einnahmen des Unternehmens (7.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: EHCDie Einnahmen des Unternehmens (8.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: EHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.2%)